NACDS pharmacy affairs chief Rosato honored as distinguished Temple alumna
ALEXANDRIA, Va. Edith Rosato, SVP pharmacy affairs for the National Association of Chain Drug Stores and president of the NACDS Foundation, was honored Friday for her achievements and leadership in the pharmacy profession.
The honor came from Rosato’s alma mater, Temple University, which named the pharmacy veteran with the distinguished 2009 Gallery of Success Award. Rosato is a 1982 graduate of the Temple University School of Pharmacy.
Each of Temple’s 17 schools and colleges annually honor two alumni who serve as inspirations to the next generation of Temple graduates. “Ms. Rosato brings over 30 years of leadership and experience in the pharmaceutical industry to her position” at NACDS, Temple noted in announcing the award. “As a registered pharmacist, she has a deep commitment to the advancement of community pharmacy and advocates for the important and integral role for pharmacists in the delivery of quality health care to patients.”
Gallery of Success award recipients, including Rosato, will have their photos and biographies displayed on the Temple University campus in Philadelphia throughout the academic year.
“Edith’s alma mater should be commended for making an outstanding selection for this high honor,” noted NACDS president and CEO Steve Anderson. “Everyone at NACDS congratulates her on her achievements and looks forward to her continued success.”
GSK drug approved for kidney cancer treatment
PHILADELPHIA The Food and Drug Administration has approved a new drug from GlaxoSmithKline to treat advanced kidney cancer.
The FDA announced the approval of Votrient (pazopanib) treatment for advanced renal cell carcinoma designed to be taken once a day. The approval is based on phase-3 trial data showing that the drug reduced the risk of tumor progression or cancer-related death by 54% compared to placebo.
“RCC is the most common malignancy of the kidney and is highly resistant to chemotherapy,” GSK Oncology R&D Unit SVP Paolo Paoletti said in a statement. “While treatment has improved in the past few years with the introduction of targeted therapies, advanced RCC remains a challenging disease.”
RCC affects more than 57,000 people and kills 13,000 in the United States every year.
Washington pharmacists can prescribe antiviral drugs, if flu pandemic hits
SEATTLE Should a major outbreak of pandemic flu hit Washington state, pharmacists there will be able to prescribe antiviral drugs, under an agreement between pharmacy groups and state health officials.
According to the Northwest Center for Public Health Practice, or NWCPHP, an organization in the University of Washington’s School of Public Health, a team from NWCPHP, the Washington State Pharmacy Association and other groups developed a template collaborative drug therapy agreement for the medications under contract with the Washington State Department of Health, supported by money from the Centers for Disease Control and Prevention.
The new protocol is intended to go into effect when local health officers authorize it.